Cannabinoids in Bipolar Affective Disorder

Status Withdrawn

Clinical Trial Summary

Some people with bipolar disorder who use cannabis (marijuana) claim that it eases the symptoms of depression and mania. There are many chemicals (called cannabinoids) found in cannabis but two particular ones appear to have medicinal (therapeutic) effects. These two compounds are: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These cannabinoids appear to have mood, anxiety, and sedative effects as well as have antipsychotic and anticonvulsant properties. This study will try to find out if these cannabinoids can be of benefit as an add-on treatment in bipolar disorder and what effects it has on thinking power and memory.

Clinical Trial Description

This study will be a within-subject, random order, double-blind cross-over study with standard clinical and neuropsychological ratings. Duration is 13 weeks per subject. Clinical assessments including mood ratings will be performed weekly. Instructions and practice on the use of the spray will be given under supervision during a 2-week run-in period before baseline. Patients can control the dosage of cannabinoids according to their symptoms by administering up to a maximum of 48 pump-controlled sprays per day. Patients will be asked to abstain from using cannabis (other than the study drug) during the study. Patients will be treated for 4 weeks with either the sublingual THC:CBD spray or placebo spray. This will be followed by a 2-week washout period before another 4 weeks of treatment with whichever study medication was not initially used. Neurocognitive testing will be performed 3 times during the study. A mood diary will be completed daily by each patient at home. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00397605
Study type	Interventional
Source	University of British Columbia
Contact
Status	Withdrawn
Phase	N/A
Start date	November 2006
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03275714` - Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder	N/A
Completed	`NCT03249857` - Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.	N/A
Completed	`NCT01722344` - Improving Work Outcome for People With Severe Mental Illness	N/A
Completed	`NCT01431092` - Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia	Phase 4
Completed	`NCT01315028` - Bipolar Intervention Study: Cognitive Interpersonal Therapy	N/A
Terminated	`NCT00805493` - Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder	Phase 2
Completed	`NCT00436020` - rTMS in the Treatment of Bipolar Depression	N/A
Recruiting	`NCT05860101` - Compassion-Focused Therapy for Distressing Mood Swings: A Case Series	N/A
Recruiting	`NCT06176456` - Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia	N/A
Terminated	`NCT03310593` - Cannabidiol as an Adjunctive Treatment for Bipolar Depression	Phase 2/Phase 3
Recruiting	`NCT05406414` - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems	N/A
Completed	`NCT02773108` - Somatic Comorbidities in Psychiatric Patients
Recruiting	`NCT00474357` - Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy	N/A
Withdrawn	`NCT00327756` - Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder	Phase 2
Completed	`NCT02453217` - The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial	N/A
Completed	`NCT05683431` - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)	N/A
Not yet recruiting	`NCT05915312` - Exosome for Early Diagnosis of Bipolar Affective Disorder
Completed	`NCT00186758` - Transcranial Magnetic Stimulation in Bipolar Depression	Phase 4
Completed	`NCT02083978` - Bipolar Research Study Using MR Imaging	N/A
Completed	`NCT00683709` - Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder	Phase 4